Copyright © 2024 广州源井生物科技有限公司 版权所有
粤ICP备19080093号
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma